{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:11:01Z","timestamp":1793506261661,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T00:00:00Z","timestamp":1445990400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-1225-0","type":"journal-article","created":{"date-parts":[[2015,10,28]],"date-time":"2015-10-28T07:06:49Z","timestamp":1446016009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Intestinal decolonization of Enterobacteriaceae producing extended-spectrum \u03b2-lactamases (ESBL): a retrospective observational study in patients at risk for infection and a brief review of the literature"],"prefix":"10.1186","volume":"15","author":[{"given":"Siegbert","family":"Rieg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Fabian","family":"K\u00fcpper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"de With","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annerose","family":"Serr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen A.","family":"Bohnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried V.","family":"Kern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,28]]},"reference":[{"key":"1225_CR1","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ijantimicag.2009.11.003","volume":"35","author":"G Peirano","year":"2010","unstructured":"Peirano G, Pitout JD. Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents. 2010;35:316\u201321.","journal-title":"Int J Antimicrob Agents"},{"key":"1225_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","volume":"8","author":"JD Pitout","year":"2008","unstructured":"Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8:159\u201366.","journal-title":"Lancet Infect Dis"},{"key":"1225_CR3","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1093\/jac\/dks301","volume":"67","author":"KZ Vardakas","year":"2012","unstructured":"Vardakas KZ, Tansarli GS, Rafailidis PI, Falagas ME. Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum beta-lactamases: a systematic review and meta-analysis. J Antimicrob Chemother. 2012;67:2793\u2013803.","journal-title":"J Antimicrob Chemother"},{"key":"1225_CR4","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1586\/14787210.6.5.671","volume":"6","author":"J Rodriguez-Bano","year":"2008","unstructured":"Rodriguez-Bano J, Pascual A. Clinical significance of extended-spectrum beta-lactamases. Expert Rev Anti Infect Ther. 2008;6:671\u201383.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"1225_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ajic.2012.09.020","volume":"41","author":"FS Zimmerman","year":"2013","unstructured":"Zimmerman FS, Assous MV, Bdolah-Abram T, Lachish T, Yinnon AM, Wiener-Well Y. Duration of carriage of carbapenem-resistant Enterobacteriaceae following hospital discharge. Am J Infect Control. 2013;41:190\u20134.","journal-title":"Am J Infect Control"},{"key":"1225_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa0800394","volume":"360","author":"AM Smet de","year":"2009","unstructured":"de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med. 2009;360:20\u201331.","journal-title":"N Engl J Med"},{"key":"1225_CR7","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.clinthera.2011.06.007","volume":"33","author":"A Rivkin","year":"2011","unstructured":"Rivkin A, Gim S. Rifaximin: new therapeutic indication and future directions. Clin Ther. 2011;33:812\u201327.","journal-title":"Clin Ther"},{"key":"1225_CR8","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1093\/jac\/dkt171","volume":"68","author":"B Huttner","year":"2013","unstructured":"Huttner B, Haustein T, Uckay I, Renzi G, Stewardson A, Schaerrer D, et al. Decolonization of intestinal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae with oral colistin and neomycin: a randomized, double-blind, placebo-controlled trial. J Antimicrob Chemother. 2013;68:2375\u201382.","journal-title":"J Antimicrob Chemother"},{"key":"1225_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1086\/663206","volume":"33","author":"L Saidel-Odes","year":"2012","unstructured":"Saidel-Odes L, Polachek H, Peled N, Riesenberg K, Schlaeffer F, Trabelsi Y, et al. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage. Infect Control Hosp Epidemiol. 2012;33:14\u20139.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1225_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.ajic.2013.04.018","volume":"41","author":"I Oren","year":"2013","unstructured":"Oren I, Sprecher H, Finkelstein R, Hadad S, Neuberger A, Hussein K, et al. Eradication of carbapenem-resistant Enterobacteriaceae gastrointestinal colonization with nonabsorbable oral antibiotic treatment: A prospective controlled trial. Am J Infect Control. 2013;41:1167\u201372.","journal-title":"Am J Infect Control"},{"key":"1225_CR11","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jhin.2010.09.022","volume":"77","author":"M Buehlmann","year":"2011","unstructured":"Buehlmann M, Bruderer T, Frei R, Widmer AF. Effectiveness of a new decolonisation regimen for eradication of extended-spectrum beta-lactamase-producing Enterobacteriaceae. J Hosp Infect. 2011;77:113\u20137.","journal-title":"J Hosp Infect"},{"key":"1225_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.ijantimicag.2013.08.008","volume":"42","author":"C Lubbert","year":"2013","unstructured":"Lubbert C, Faucheux S, Becker-Rux D, Laudi S, Durrbeck A, Busch T, et al. Rapid emergence of secondary resistance to gentamicin and colistin following selective digestive decontamination in patients with KPC-2-producing Klebsiella pneumoniae: a single-centre experience. Int J Antimicrob Agents. 2013;42:565\u201370.","journal-title":"Int J Antimicrob Agents"},{"key":"1225_CR13","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1093\/jac\/dks187","volume":"67","author":"EA Oostdijk","year":"2012","unstructured":"Oostdijk EA, de Smet AM, Kesecioglu J, Bonten MJ. Decontamination of cephalosporin-resistant Enterobacteriaceae during selective digestive tract decontamination in intensive care units. J Antimicrob Chemother. 2012;67:2250\u20133.","journal-title":"J Antimicrob Chemother"},{"key":"1225_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1089\/mdr.2010.0060","volume":"17","author":"F Abecasis","year":"2011","unstructured":"Abecasis F, Sarginson RE, Kerr S, Taylor N, van Saene HK. Is selective digestive decontamination useful in controlling aerobic gram-negative bacilli producing extended spectrum beta-lactamases? Microb Drug Resist. 2011;17:17\u201323.","journal-title":"Microb Drug Resist"},{"key":"1225_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1086\/502521","volume":"26","author":"G Troche","year":"2005","unstructured":"Troche G, Joly LM, Guibert M, Zazzo JF. Detection and treatment of antibiotic-resistant bacterial carriage in a surgical intensive care unit: a 6-year prospective survey. Infect Control Hosp Epidemiol. 2005;26:161\u20135.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1225_CR16","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1001\/jama.2012.264","volume":"307","author":"M Nitschke","year":"2012","unstructured":"Nitschke M, Sayk F, Hartel C, Roseland RT, Hauswaldt S, Steinhoff J, et al. Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. JAMA. 2012;307:1046\u201352.","journal-title":"JAMA"},{"key":"1225_CR17","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1086\/320882","volume":"33","author":"DL Paterson","year":"2001","unstructured":"Paterson DL, Singh N, Rihs JD, Squier C, Rihs BL, Muder RR. Control of an outbreak of infection due to extended-spectrum beta-lactamase--producing Escherichia coli in a liver transplantation unit. Clin Infect Dis. 2001;33:126\u20138.","journal-title":"Clin Infect Dis"},{"key":"1225_CR18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/QCO.0b013e3283398dc1","volume":"23","author":"J Oteo","year":"2010","unstructured":"Oteo J, Perez-Vazquez M, Campos J. Extended-spectrum [beta]-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr Opin Infect Dis. 2010;23:320\u20136.","journal-title":"Curr Opin Infect Dis"},{"key":"1225_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.diagmicrobio.2012.05.020","volume":"74","author":"Y Doi","year":"2012","unstructured":"Doi Y, Adams-Haduch JM, Peleg AY, D\u2019Agata EM. The role of horizontal gene transfer in the dissemination of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in an endemic setting. Diagn Microbiol Infect Dis. 2012;74:34\u20138.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"1225_CR20","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s10096-010-1031-y","volume":"29","author":"K Kennedy","year":"2010","unstructured":"Kennedy K, Collignon P. Colonisation with Escherichia coli resistant to \u201ccritically important\u201d antibiotics: a high risk for international travellers. Eur J Clin Microbiol Infect Dis. 2010;29:1501\u20136.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1225_CR21","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ajic.2012.05.015","volume":"41","author":"G Birgand","year":"2013","unstructured":"Birgand G, Armand-Lefevre L, Lolom I, Ruppe E, Andremont A, Lucet JC. Duration of colonization by extended-spectrum beta-lactamase-producing Enterobacteriaceae after hospital discharge. Am J Infect Control. 2013;41:443\u20137.","journal-title":"Am J Infect Control"},{"key":"1225_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1086\/659762","volume":"32","author":"V Schechner","year":"2011","unstructured":"Schechner V, Kotlovsky T, Tarabeia J, Kazma M, Schwartz D, Navon-Venezia S, et al. Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter. Infect Control Hosp Epidemiol. 2011;32:497\u2013503.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"1225_CR23","doi-asserted-by":"publisher","first-page":"O508","DOI":"10.1111\/1469-0691.12559","volume":"20","author":"E Titelman","year":"2014","unstructured":"Titelman E, Hasan CM, Iversen A, Naucler P, Kais M, Kalin M, et al. Faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae is common 12\u00a0months after infection and is related to strain factors. Clin Microbiol Infect. 2014;20:O508\u201315.","journal-title":"Clin Microbiol Infect"},{"key":"1225_CR24","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1128\/AAC.44.8.2205-2206.2000","volume":"44","author":"ZD Jiang","year":"2000","unstructured":"Jiang ZD, Ke S, Palazzini E, Riopel L, Dupont H. In vitro activity and fecal concentration of rifaximin after oral administration. Antimicrob Agents Chemother. 2000;44:2205\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"1225_CR25","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1128\/JCM.06852-11","volume":"50","author":"M Gazin","year":"2012","unstructured":"Gazin M, Paasch F, Goossens H, Malhotra-Kumar S. Current trends in culture-based and molecular detection of extended-spectrum-beta-lactamase-harboring and carbapenem-resistant Enterobacteriaceae. J Clin Microbiol. 2012;50:1140\u20136.","journal-title":"J Clin Microbiol"},{"key":"1225_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1128\/JCM.01953-10","volume":"49","author":"IT Overdevest","year":"2011","unstructured":"Overdevest IT, Willemsen I, Elberts S, Verhulst C, Kluytmans JA. Laboratory detection of extended-spectrum-beta-lactamase-producing Enterobacteriaceae: evaluation of two screening agar plates and two confirmation techniques. J Clin Microbiol. 2011;49:519\u201322.","journal-title":"J Clin Microbiol"},{"key":"1225_CR27","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1128\/JCM.00378-15","volume":"53","author":"N Stoesser","year":"2015","unstructured":"Stoesser N, Sheppard AE, Moore CE, Golubchik T, Parry CM, Nget P, et al. Extensive Within-Host Diversity in Fecally Carried Extended-Spectrum-Beta-Lactamase-Producing Escherichia coli Isolates: Implications for Transmission Analyses. J Clin Microbiol. 2015;53:2122\u201331.","journal-title":"J Clin Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1225-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-1225-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1225-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T22:23:08Z","timestamp":1498256588000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-1225-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,28]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1225"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-1225-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,28]]},"article-number":"475"}}